As reported by Xconomy:
Investors continue to pour millions of dollars into startups attempting to apply artificial intelligence technologies to various problems in healthcare.
The latest beneficiary is PathAI, a Cambridge, MA-based company developing A.I. software aimed at helping pathologists be more efficient and accurate in diagnosing disease. PathAI co-founder and CEO Andy Beck tells Xconomy that his company just raised $11 million in a Series A funding round led by General Catalyst Partners. Other investors in the round included Pillar Companies, Refactor Capital, 8VC, Danhua Capital, and KdT Ventures, Beck (pictured above) says. The investment brings PathAI’s total venture capital haul to $15 million, he says... READ MORE